Results 1-34 of 34 (Search time: 0.026 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12023Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic CancerSu, Yung-Yeh; Chiang, Nai-Jung; Yang, Yi-Hsin; Yen, Chia-Jui; Bai, Li-Yuan; Chiu, Chang-Fang; Chuang, Shih-Chang; SHIH HUNG YANG ; Chou, Wen-Chi; Chen, Jen-Shi; Chiu, Tai-Jan; Chen, Yen-Yang; Chan, De-Chuan; Peng, Cheng-Ming; Chiu, Sz-Chi; Li, Chung-Pin; Shan, Yan-Shen; Chen, Li-TzongCancers00
22022Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorinChiu, Tai-Jan; SHIH-HUNG YANG ; Chiu, Sz-Chi; Hsueh, Shun-Wen; Chiang, Nai-Jung; Li, Chung-Pin; Bai, Li-Yuan; Cheng, Fu-Ming; Chuang, Shih-Chang; Shan, Yan-Shen; Chan, De-Chuan; Chen, Li-Tzong; Yen, Chia-Jui; Peng, Cheng-Ming; Su, Yung-Yeh; Chen, Yen-Yang; Chen, Jen-Shi; Chou, Wen-ChiJournal of hepato-biliary-pancreatic sciences22
32022Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive RadiotherapyChen, Yi Lun; CHIAO-LING TSAI ; CHIA-HSIEN CHENG ; CHUN-WEI WANG ; SHIH-HUNG YANG ; YU-WEN TIEN ; SUNG-HSIN KUO Frontiers in Oncology10
42022Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic AdenocarcinomaSHIH-HUNG YANG ; JEN-CHIEH LEE ; BANG-BIN CHEN ; SUNG-HSIN KUO ; CHIUN HSU ; Bai, Li-YuanFrontiers in Immunology00
52022Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline mutation of MSH6: A case reportPeng, Shang-Hsuan; BANG-BIN CHEN ; TING-CHUN KUO ; JEN-CHIEH LEE ; SHIH HUNG YANG Frontiers in immunology11
62022A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 studySu, Yung-Yeh; Chiu, Yen-Feng; Li, Chung-Pin; SHIH-HUNG YANG ; Lin, Johnson; Lin, Shyh-Jer; Chang, Ping-Ying; Chiang, Nai-Jung; Shan, Yan-Shen; Ch'ang, Hui-Ju; Chen, Li-TzongBritish journal of cancer57
72022Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter StudySu, Yung-Yeh; Chiang, Nai-Jung; Li, Chung-Pin; Yen, Chia-Jui; SHIH-HUNG YANG ; Chou, Wen-Chi; Chen, Jen-Shi; Chiu, Tai-Jan; Chen, Yen-Yang; Chuang, Shih-Chang; Bai, Li-Yuan; Chiu, Chang-Fang; Peng, Cheng-Ming; Chan, De-Chuan; Chiu, Sz-Chi; Yang, Yi-Hsin; Shan, Yan-Shen; Chen, Li-TzongFrontiers in oncology23
82021Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinomaChuang, Pei-Ju; HSIU-PO WANG ; Lin, Yu-Jen; CHIEH-CHANG CHEN ; YU-WEN TIEN ; MIN-SHU HSIEH ; SHIH-HUNG YANG ; RUOH-FANG YEN ; CHI-LUN KO ; YEN-WEN WU ; MEI-FANG CHENG European radiology32
92021Metabolic Alterations in Pancreatic Cancer Detected by In Vivo 1H-MR Spectroscopy: Correlation with Normal Pancreas, PET Metabolic Activity, Clinical Stages, and Survival OutcomeChang, Chih-Kai; TIFFANY TING-FANG SHIH ; YU-WEN TIEN ; MING-CHU CHANG ; YU-TING CHANG ; SHIH-HUNG YANG ; MEI-FANG CHENG ; BANG-BIN CHEN Diagnostics (Basel, Switzerland)44
102021Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signalingSUNG-HSIN KUO ; SHIH-HUNG YANG ; Wei, Ming-Feng; Lee, Hsiao-Wei; YU-WEN TIEN ; ANN-LII CHENG ; KUN-HUEI YEH Cancer cell international33
112021C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin αvKuo, Ting-Chun; MING-HSUN WU ; SHIH-HUNG YANG ; Chen, Syue-Ting; Hsu, Tzu-Wen; Jhuang, Jie-Yang; Liao, Ying-Yu; YU-WEN TIEN ; MIN-CHUAN HUANG Oncogene1817
122021Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinomaSHIH-HUNG YANG ; LI-CHUN LU ; HSIANG-FONG KAO ; BANG-BIN CHEN ; TING-CHUN KUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; Bai, Li-Yuan; ANN-LII CHENG ; KUN-HUEI YEH Oncoimmunology23
132021Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based studyChiu T.-J.; Su Y.-Y.; SHIH-HUNG YANG ; Li C.-P.; Bai L.-Y.; Chiang N.-J.; Chuang S.-C.; Shan Y.-S.; Chan D.-C.; Chen L.-T.; Yen C.-J.; Peng C.-M.; Chen Y.-Y.; Chen J.-S.; Chou W.-C.Therapeutic Advances in Medical Oncology35
142020S-1–associated hypertriglyceridemia in a patient with pancreatic adenocarcinomaChen H.-W.; HUNG-YANG KUO ; BANG-BIN CHEN ; YU-WEN TIEN ; SUNG-HSIN KUO ; SHIH-HUNG YANG Journal of Oncology Practice00
152020Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 studyChiang N.-J.; Chen M.-H.; SHIH-HUNG YANG ; CHIUN HSU ; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.Liver International55
162020Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patientsSHIH-HUNG YANG ; JHE-CYUAN GUO ; CHIUN HSU ; SUNG-HSIN KUO ; YU-WEN TIEN ; ANN-LII CHENG ; KUN-HUEI YEH Journal of the Formosan Medical Association33
172020A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 studyChiang N.-J.; Tsai K.K.; Hsiao C.-F.; SHIH-HUNG YANG ; Hsiao H.-H.; Shen W.-C.; CHIUN HSU ; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T.European Journal of Cancer88
182019Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic CancerWu, Hsu; JHE-CYUAN GUO ; SHIH-HUNG YANG ; YU-WEN TIEN ; SUNG-HSIN KUO Journal of clinical medicine66
192018A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinomaSHIH-HUNG YANG ; YU-YUN SHAO ; CHIA-CHI LIN ; SUNG-HSIN KUO ; ANN-LII CHENG ; KUN-HUEI YEH Anticancer Research32
202018Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancerBANG-BIN CHEN ; YU-WEN TIEN ; MING-CHU CHANG ; MEI-FANG CHENG ; YU-TING CHANG ; SHIH-HUNG YANG ; CHIH-HORNG WU ; TING-CHUN KUO ; I-LUN SHIH ; RUOH-FANG YEN ; TIFFANY TING-FANG SHIH European Journal of Nuclear Medicine and Molecular Imaging3228
212017Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapySHIH-HUNG YANG ; JEN-CHIEH LEE ; JHE-CYUAN GUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; TING-CHUN KUO ; ANN-LII CHENG ; KUN-HUEI YEH PLoS ONE63
222017Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in TaiwanMING-CHU CHANG ; CHIH-HORNG WU ; SHIH HUNG YANG ; PO-CHIN LIANG ; BANG-BIN CHEN ; I-SHIOW JAN ; YU-TING CHANG ; YUNG-MING JENG American Journal of Cancer Research15
232016Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancerSHIH-HUNG YANG ; TING-CHUN KUO ; Wu H.; JHE-CYUAN GUO ; CHIUN HSU ; CHIH-HUNG HSU ; YU-WEN TIEN ; KUN-HUEI YEH ; ANN-LII CHENG ; SUNG-HSIN KUO World Journal of Gastroenterology2325
242016PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosisBANG-BIN CHEN ; YU-WEN TIEN ; MING-CHU CHANG ; MEI-FANG CHENG ; YU-TING CHANG ; CHIH-HORNG WU ; Chen X.-J.; TING-CHUN KUO ; SHIH-HUNG YANG ; I-LUN SHIH ; HONG-SHIEE LAI ; TIFFANY TING-FANG SHIH European Journal of Nuclear Medicine and Molecular Imaging5049
252016Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancerSHIH-HUNG YANG ; JHE-CYUAN GUO ; KUN-HUEI YEH ; YU-WEN TIEN ; ANN-LII CHENG ; SUNG-HSIN KUO Journal of Gastroenterology and Hepatology (Australia)77
262016Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinomaMING-CHU CHANG ; YU-TING CHANG ; Chen J.-Y.; YUNG-MING JENG ; CHING-YAO YANG ; YU-WEN TIEN ; SHIH-HUNG YANG ; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H.Clinical Chemistry7269
272014Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: A retrospective studyJHE-CYUAN GUO ; SHIH-HUNG YANG International Journal of Clinical Oncology22
282013Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κb is associated with a poor prognosis of pancreatic cancerSHIH-HUNG YANG ; CHIH-HUNG HSU ; JEN-CHIEH LEE ; YU-WEN TIEN ; SUNG-HSIN KUO ; ANN-LII CHENG Oncology (Switzerland)2420
292012Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphomaSHIH-HUNG YANG ; Lin L.-W.; YU-JEN FANG ; ANN-LII CHENG ; SUNG-HSIN KUO Annals of Hematology52
302012A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumorSHIH-HUNG YANG ; CHIA-CHI LIN ; ZHONG-ZHE LIN ; Tseng Y.-L.; RUEY-LONG HONG Investigational New Drugs3327
312012Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapyKuo Y.-H.; CHING-HUNG LIN ; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG ; Huang S.-M.; CHIUN HSU ; YEN-SHEN LU ; ANN-LII CHENG BMC Cancer1816
322011Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trialsSHIH-HUNG YANG ; Kuo Y.-H.; YU-WEN TIEN ; CHIUN HSU ; CHIH-HUNG HSU ; SUNG-HSIN KUO ; ANN-LII CHENG Oncology1313
332009Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphomaSHIH-HUNG YANG ; ZHONG-ZHE LIN ; SUNG-HSIN KUO ; ANN-LII CHENG American Journal of Hematology11
342008Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma [2]SHIH-HUNG YANG ; SUNG-HSIN KUO Annals of Hematology2522